GSK position history
The shares of GSK that Tweedy, Browne Co LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q4: 139,327 shares, $4.9M, 0.26% of portfolio, New
- 2023 Q1: 135,375 shares, $4.8M, 0.26% of portfolio, Reduce −2.8%
- 2023 Q2: 134,514 shares, $4.8M, 0.25% of portfolio, Reduce −0.6%
- 2023 Q3: 129,994 shares, $4.7M, 0.25% of portfolio, Reduce −3.4%
- 2023 Q4: 124,400 shares, $4.6M, 0.23% of portfolio, Reduce −4.3%
- 2024 Q1: 123,044 shares, $5.3M, 0.25% of portfolio, Reduce −1.1%
- 2024 Q2: 109,855 shares, $4.2M, 0.19% of portfolio, Reduce −10.7%
- 2024 Q3: 108,035 shares, $4.4M, 0.21% of portfolio, Reduce −1.7%
- 2024 Q4: 93,816 shares, $3.2M, 0.21% of portfolio, Reduce −13.2%
- 2025 Q1: 90,545 shares, $3.5M, 0.31% of portfolio, Reduce −3.5%
- 2025 Q2: 86,871 shares, $3.3M, 0.31% of portfolio, Reduce −4.1%
- 2025 Q3: 82,243 shares, $3.5M, 0.31% of portfolio, Reduce −5.3%
- 2025 Q4: 82,243 shares, $4M, 0.33% of portfolio
- 2026 Q1: 81,785 shares, $4.5M, 0.36% of portfolio, Reduce −0.6%
- 2026 Q2: 81,527 shares, $4.3M, 0.32% of portfolio, Reduce −0.3%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|